Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NORRIS.BOthis companyNorris Medicines Limited	₹14.25	-47.32×	-0.88×	1.63×	48.99×	-220.4%	47.1%	26.5%	-3.5%	1.9%	33.8%	4.3%	-1.42×	30.29×	0×	0.61×	0.0%	2	—	1	D+
BERLDRG.BOBeryl Drugs Limited	₹25.49	22.95×	0.99×	0.5×	4.91×	-329.6%	28.6%	4.8%	2.2%	4.3%	5.2%	-5.3%	0.25×	0.89×	2.71×	1.52×	0.0%	5	3.87	1	C-
EMMESSA.BOEmmessar Biotech & Nutrition Limited	₹23.98	29.09×	1.56×	34.19×	-3.96×	-56.4%	-241.7%	-392.0%	117.6%	5.4%	-12.0%	5.1%	0×	5.41×	-581.48×	20.27×	0.0%	3	—	3	B-
EVOQ.BOEvoq Remedies Ltd.	₹1.60	-25.2×	0.14×	0.24×	-30.58×	-7336.2%	0.1%	-5.9%	-0.9%	-0.5%	-3.2%	-4.7%	0×	-0.34×	0×	6.77×	0.0%	3	1.82	2	B-
NONOVATEOR.BONovateor Research Laboratories	₹32.56	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
PARMAX.BOParmax Pharma Limited	₹135.00	-2.83×	-1.91×	0.97×	-6.3×	-153.2%	18.4%	-38.4%	-34.3%	67.7%	-56.0%	-27.7%	-1.87×	-3.03×	-3.75×	0.74×	0.0%	—	—	1	D+
Peer median	—	10.06×	0.56×	0.74×	-5.13×	-241.4%	9.3%	-22.1%	0.6%	4.8%	-7.6%	-5.0%	0×	0.28×	-1.88×	4.15×	0.0%	3	2.85	2	—